# CRISPR Therapeutics

> Gene-based medicine development

Business model and tags: B2B, Publicly traded, Multi-product, Pharma & life sciences, Parent company, International operations, Has in-house R&D

## About CRISPR Therapeutics

A leading gene editing company developing gene-based medicines for serious diseases, using CRISPR/Cas9 technology and collaborating with industry leaders

## Key facts

- **Industry**: Biotechnology Research
- **Company size**: 251–1,000 employees
- **Headquarters**: boston, massachusetts, United States
- **Founded**: 2013
- **Revenue**: $3.5M (FY2025, publicly reported)
- **Website**: [crisprtx.com](https://crisprtx.com/)
- **LinkedIn**: [linkedin.com/company/crispr-therapeutics](https://www.linkedin.com/company/crispr-therapeutics)

## CRISPR Therapeutics at a glance

CRISPR Therapeutics is a B2B company in the Biotechnology Research industry, headquartered in boston, massachusetts, United States.

CRISPR Therapeutics was founded in 2013.

CRISPR Therapeutics has 251–1,000 employees.

CRISPR Therapeutics's revenue is $3.5M (FY2025, publicly reported).

## Frequently asked questions about CRISPR Therapeutics

### What is CRISPR Therapeutics's revenue?

CRISPR Therapeutics's revenue is $3.5M (FY2025, publicly reported).

### How many employees does CRISPR Therapeutics have?

CRISPR Therapeutics has 251–1,000 employees.

### Where is CRISPR Therapeutics headquartered?

CRISPR Therapeutics is headquartered in boston, massachusetts, United States.

---

Company data compiled by Tamtam from public sources and Tamtam's own analysis. Figures marked as estimates are modelled, not reported.

Source: https://www.tamtam.ai/c/crispr-therapeutics
